Global Giants

Kevin Ali CEO Organon Heads Jersey City-based Organon, a spinoff from Merck, which believes the journey to improve women’s health is critical to achieving a healthier world, and it works tirelessly toward its goal of finding solutions...

Ken Frazier  Executive chairman Merck Frazier continues to guide Merck from his chair role — and continues to be a source of counsel for business leaders and government leaders around the state and around the county, most...

Sherine Aly  Founder and CEO BioCentric Runs a privately held, full-service global medical and scientific health care communications and training company that develops programs for the pharmaceutical, biotechnology and device industries; medical and health care associations; and...

Patrick Lockwood-Taylor  President, U.S. Bayer In addition to being responsible for all U.S. activities of the worldwide Bayer group, he also serves a dual role as regional president of consumer health North America. Doug LangaJohn Oyler  

Bill Hanlon  President, CDCS, clinical therapeutic & regulatory sciences, and chief scientific officer Labcorp Drug Development Hanlon has responsibility for all the scientific, therapeutic, market access & regulatory expertise, patient recruitment, medical device & diagnostics development, cell...

Robert Davis  CEO Merck Merck was named to Fortune’s 2022 Change the World — an annual list that recognizes companies that have had a positive social impact through activities that are part of their core business strategy. James...

James Davis  Incoming CEO Quest Diagnostics Davis, who joined Quest in 2013, will become CEO on Nov. 1, succeeding Steve Rusckowski. Davis currently oversees Quest’s diagnostics business, which accounts for over 80% of the company’s more than...

Ken Keller  CEO Daiichi Sankyo U.S. Veteran health care exec, who also heads Daiichi Sankyo’s global oncology business, has successfully launched numerous biologic products in therapeutic areas ranging from oncology to bone health to nephrology to inflammatory...

Victor Bulto  President, Innovative Medicines U.S. Novartis Bulto, the former president of Novartis Pharmaceuticals, is now helping company pursue a bold strategy to reimagine medicine and deliver on its responsibility to unlock the potential for helping patients...

Joaquin Duato  CEO Johnson & Johnso Among first duties as CEO was helping the company split off its consumer brands products into a new brand, Kenvue, which will begin operating next year. Robert DavisKen Frazier